Breathonix develops non-invasive breath tests for disease detection. Using its proprietary breath sampling device and data analysis algorithms, Breathonix has successfully demonstrated the detection of Covid-19, early-stage lung cancer, as well as misdiagnosed Tuberculosis. Breathonix’s technology can complete one breath test within 1 minute and with high level of accuracy. Our Vision is to become the global leader in non-invasive breath tests for disease detection.